Mirae Asset Securities (Usa) Inc. Crispr Therapeutics Ag Transaction History
Mirae Asset Securities (Usa) Inc.
- $2.11 Trillion
- Q2 2024
A detailed history of Mirae Asset Securities (Usa) Inc. transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Mirae Asset Securities (Usa) Inc. holds 7,534 shares of CRSP stock, worth $381,145. This represents 0.02% of its overall portfolio holdings.
Number of Shares
7,534Holding current value
$381,145% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding CRSP
# of Institutions
505Shares Held
57.3MCall Options Held
1.74MPut Options Held
1.84M-
Capital International Investors Los Angeles, CA7.87MShares$398 Million0.09% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.5MShares$379 Million3.35% of portfolio
-
Nikko Asset Management Americas, Inc.3.15MShares$159 Million1.99% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.97MShares$150 Million0.1% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$141 Million0.0% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $3.95B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....